The Florida Pediatric Community Clinical Oncology Program is a consortium of four hospitals (All Children's Hospital, Jacksonville Wolfson Children's Hospital, Orlando Regional Medical Center, and Sacred Heart Children's Hospital) and the Puerto Rico Pediatric Oncology Program which seeks to affiliate with the Pediatric Oncology Group as its Research Base. Since 1983, the Florida hospitals have been federally supported as a CCOP affiliating with the POG. They complement the three major university teaching hospitals in the state which are also Pediatric Oncology Group members. These hospitals geographically cover the entire state of Florida. Since their catchment area includes patients referred from the Caribbean, the Puerto Rico Pediatric Oncology Program of San Juan, Puerto Rico has recently been added. The goal of the Florida Pediatric CCOP is to make available the latest advances in cancer care to patients in Florida and the Caribbean through participation in clinical trials. In addition, the CCOP members will actively participate in cancer control research protocols. They provide a unique opportunity to study a geographically-defined population to investigate risk factors, patterns of care and population-based interventions. The CCOP participants will utilize the existing Statewide Patient Information Reporting System as a log of all patients seen in this geographically-defined area. Patients will be registered on POG protocols through the Pediatric Oncology Group Statistical Office which is co-located with the Central Office of the Florida Pediatric CCOP. This unique arrangement affords the opportunity to ensure the majority of eligible patients are registered on appropriate POG protocols. Over 85 patient registrations are anticipated per year on POG treatment protocols and 29 on existing cancer control protocols per year through the five participating centers of the Florida Pediatric CCOP. POG quality control procedures will be extended to include the Florida CCOP, ensuring compliance with protocols and external review of pathology, radiotherapy, surgery and chemotherapy.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
Application #
Study Section
Special Emphasis Panel (SRC (54))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Florida Assn of Pediatric Tumor Prog
United States
Zip Code
Roy, Hemant K; Turzhitsky, Vladimir; Wali, Ramesh et al. (2017) Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin. Gut 66:285-292
Jovanovic, Borko D; Subramanian, Hariharan; Helenowski, Irene B et al. (2015) Clinical Trial Laboratory Data Nested With in Subject: Components of Variance, Sample Size and Cost. Biom Biostat Int J 2:
Lee, Oukseub; Page, Katherine; Ivancic, David et al. (2014) A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast. Clin Cancer Res 20:3672-82
Wong, Stuart J; Campbell, Bruce; Massey, Becky et al. (2013) A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. Oral Oncol 49:970-976
Khan, Seema A; Chatterton, Robert T; Michel, Nancy et al. (2012) Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial. Cancer Prev Res (Phila) 5:309-19
Marshall, James R; Ip, Clement; Romano, Karen et al. (2011) Methyl selenocysteine: single-dose pharmacokinetics in men. Cancer Prev Res (Phila) 4:1938-44
Xu, Li; Wang, Sophia S; Healey, Megan A et al. (2011) The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research. Cancer Prev Res (Phila) 4:616-21
Pavese, Janet M; Farmer, Rebecca L; Bergan, Raymond C (2010) Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev 29:465-82
Grundy, P; Wilson, B; Telzerow, P et al. (1994) Uniparental disomy occurs infrequently in Wilms tumor patients. Am J Hum Genet 54:282-9
Montalvo, F W; Casanova, R; Clavell, L A (1990) Treatment outcome in children with malignancies associated with human immunodeficiency virus infection. J Pediatr 116:735-8

Showing the most recent 10 out of 11 publications